Should I buy or sell Neogen stock right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Neogen in the last year. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" NEOG shares. View NEOG analyst ratings or view top-rated stocks .

What is Neogen's stock price target for 2024?

2 Wall Street research analysts have issued 12 month target prices for Neogen's shares. Their NEOG share price targets range from $17.50 to $28.00. On average, they predict the company's share price to reach $22.75 in the next twelve months. This suggests a possible upside of 34.2% from the stock's current price. View analysts price targets for NEOG or view top-rated stocks among Wall Street analysts .

How have NEOG shares performed in 2023?

Neogen's stock was trading at $15.23 on January 1st, 2023. Since then, NEOG shares have increased by 11.3% and is now trading at $16.95. View the best growth stocks for 2023 here .

When is Neogen's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, January 4th 2024. View our NEOG earnings forecast .

How were Neogen's earnings last quarter?

Neogen Co. (NASDAQ:NEOG) posted its earnings results on Tuesday, October, 10th. The company reported $0.11 EPS for the quarter, topping analysts' consensus estimates of $0.03 by $0.08. The firm earned $229 million during the quarter, compared to analyst estimates of $231.10 million. Neogen had a positive trailing twelve-month return on equity of 3.57% and a negative net margin of 2.89%. The firm's revenue was up 72.8% compared to the same quarter last year. During the same period last year, the firm posted $0.15 earnings per share.

What ETFs hold Neogen's stock?

ETFs with the largest weight of Neogen (NASDAQ:NEOG) stock in their portfolio include SPDR S&P Health Care Equipment ETF (XHE) , iShares Emergent Food and AgTech Multisector ETF (IVEG) , VanEck Agribusiness ETF (MOO) , Franklin U.S. Small Cap Multifactor Index ETF (FLQS) , ProShares MSCI Transformational Changes ETF (ANEW) , iShares Russell 2000 Value ETF (IWN) , Invesco S&P MidCap 400 GARP ETF (EWMC) and iShares Russell 2000 ETF (IWM) .

When did Neogen's stock split?

Neogen's stock split before market open on Tuesday, January 2nd 2018. The 4-3 split was announced on Friday, December 8th 2017. The newly issued shares were distributed to shareholders after the market closes on Friday, December 29th 2017. An investor that had 100 shares of stock prior to the split would have 133 shares after the split.

What guidance has Neogen issued on next quarter's earnings?

Neogen updated its FY 2024 earnings guidance on Tuesday, October, 10th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $955.00 million-$985.00 million, compared to the consensus revenue estimate of $968.41 million.

What is John Adent's approval rating as Neogen's CEO?

31 employees have rated Neogen Chief Executive Officer John Adent on Glassdoor.com . John Adent has an approval rating of 56% among the company's employees. This puts John Adent in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Neogen own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Neogen investors own include NVIDIA (NVDA) , NIKE (NKE) , Pfizer (PFE) , AT&T (T) , AbbVie (ABBV) , Boeing (BA) , JPMorgan Chase & Co. (JPM) , W. P. Carey (WPC) , Advanced Micro Devices (AMD) and Costco Wholesale (COST) .

Who are Neogen's major shareholders?

Neogen's stock is owned by a variety of institutional and retail investors. Top institutional investors include Conestoga Capital Advisors LLC (3.03%), Bamco Inc. NY (2.81%), Morgan Stanley (2.64%), Mackenzie Financial Corp (2.48%), William Blair Investment Management LLC (2.22%) and JPMorgan Chase & Co. (1.85%). Insiders that own company stock include Bruce Papesh , Darci L Vetter , David H Naemura , Douglas Edward Jones , James P Tobin , Jason Warren Lilly , John Edward Adent , Ronald D Green , Steven J Quinlan , Terri A Morrical and William T Boehm . View institutional ownership trends .

How do I buy shares of Neogen?

Shares of NEOG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull , Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here .

Neogen Stock Price, News & Analysis (NASDAQ:NEOG)

$16.95

+0.35 (+2.11%)

(As of 11/29/2023 ET)

Compare

Today's Range: $16.72
▼
$17.15
50-Day Range: $14.65
▼
$19.46
52-Week Range: $14.37
▼
$24.09

Volume: 1.63 million shs
Average Volume: 1.36 million shs
Market Capitalization: $3.67 billion

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $22.75

Neogen MarketRank™ Stock Analysis

Analyst Rating: Moderate Buy
2.50 Rating Score
Upside/Downside: 34.2% Upside
$22.75 Price Target
Short Interest: Bearish
6.23% of Shares Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: N/A
Insider Trading: Acquiring Shares
$334,100 Bought Last Quarter
Proj. Earnings Growth: 32.20%
From $0.59 to $0.78 Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.16 out of 5 stars

Medical Sector

372nd out of 949 stocks

Diagnostic Substances Industry

4th out of 14 stocks

3.3

Analyst's Opinion

Consensus Rating
Neogen has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 1 buy rating, 1 hold rating, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $22.75, Neogen has a forecasted upside of 34.2% from its current price of $16.95.
Amount of Analyst Coverage
Neogen has only been the subject of 1 research reports in the past 90 days.

1.0

Short Interest

Percentage of Shares Shorted
6.23% of the outstanding shares of Neogen have been sold short.
Short Interest Ratio / Days to Cover
Neogen has a short interest ratio ("days to cover") of 7.9.
Change versus previous month
Short interest in Neogen has recently increased by 6.82%, indicating that investor sentiment is decreasing significantly.

0.0

Dividend Strength

Dividend Yield
Neogen does not currently pay a dividend.
Dividend Growth
Neogen does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for NEOG.

1.6

News and Social Media Coverage

News Sentiment
Neogen has a news sentiment score of 0.83. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
News Coverage This Week
MarketBeat has tracked 1 news article for Neogen this week, compared to 3 articles on an average week.
MarketBeat Follows
Only 2 people have added Neogen to their MarketBeat watchlist in the last 30 days. This is a decrease of -60% compared to the previous 30 days.

3.3

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Neogen insiders have bought 340.63% more of their company's stock than they have sold. Specifically, they have bought $334,100.00 in company stock and sold $75,823.00 in company stock.
Percentage Held by Insiders
Only 0.71% of the stock of Neogen is held by insiders.
Percentage Held by Institutions
96.73% of the stock of Neogen is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

1.9

Earnings and Valuation

Earnings Growth
Earnings for Neogen are expected to grow by 32.20% in the coming year, from $0.59 to $0.78 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Neogen is -154.09, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Neogen is -154.09, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Neogen has a P/B Ratio of 1.17. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Neogen Stock (NASDAQ:NEOG)

Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods. The segment offers its products primarily to milling and grain, meat and poultry, prepared foods and ingredients, fruits and vegetables, seafood, dairy, beverage, water, healthcare, traditional culture media markets, food service, and dietary supplements markets. The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products, and genomics testing services marketed through veterinarians, retailers, livestock producers, and animal health product distributors, for the animal safety market. The segment offers its products for companion animal veterinarians; livestock producers, veterinarians, and breed associations; retailers; breeding and genetics companies; diagnostic labs and universities; distributors; and other manufacturers and government agencies. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.

NEOG Stock Price History

30 days | 90 days | 365 days | Advanced Chart

NEOG Stock News Headlines

November 21, 2023 | finance.yahoo.com

Neogen® to Participate in the Piper Sandler 35th Annual Healthcare Conference

November 17, 2023 | msn.com

Neogen's (NEOG) Innovation Aids, Currency Headwind Stays

November 30, 2023 | Tomorrow Investor (Ad)

Why Microsoft Just Placed A Huge Bet On Nuclear

Even with aggressive expansion and acquisition of solar and wind farms, renewable energy isn’t anywhere close to providing the energy that Microsoft demands.

November 9, 2023 | finance.yahoo.com

Neogen (NEOG) Up 3.6% Since Last Earnings Report: Can It Continue?

October 31, 2023 | finance.yahoo.com

The past three years for Neogen (NASDAQ:NEOG) investors has not been profitable

October 26, 2023 | finance.yahoo.com

Insider Buying: Douglas Jones Acquires 10,000 Shares of Neogen Corp

October 17, 2023 | seekingalpha.com

Neogen Struggling Through An Awkward Transition

October 17, 2023 | msn.com

Piper Sandler Maintains Neogen (NEOG) Neutral Recommendation

November 30, 2023 | Tomorrow Investor (Ad)

Why Microsoft Just Placed A Huge Bet On Nuclear

Even with aggressive expansion and acquisition of solar and wind farms, renewable energy isn’t anywhere close to providing the energy that Microsoft demands.

October 16, 2023 | markets.businessinsider.com

Piper Sandler Sticks to Its Hold Rating for Neogen (NEOG)

October 13, 2023 | proactiveinvestors.com

Neogen set make a quiet start to new financial year

October 12, 2023 | finance.yahoo.com

Neogen Corporation (NASDAQ:NEOG) Q1 2024 Earnings Call Transcript

October 12, 2023 | finance.yahoo.com

Insider Buying: CFO David Naemura Acquires 10,000 Shares of Neogen Corp

October 11, 2023 | seekingalpha.com

Neogen says CFO Naemura buys 10K shares

October 11, 2023 | finance.yahoo.com

Neogen (NEOG) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

October 11, 2023 | finance.yahoo.com

Q1 2024 Neogen Corp Earnings Call

October 10, 2023 | markets.businessinsider.com

Crude Oil Moves Lower; Neogen Posts Downbeat Results

October 10, 2023 | finance.yahoo.com

Neogen Corp (NEOG) Reports First-Quarter 2024 Results: Revenue Soars by 73%

October 10, 2023 | msn.com

Neogen Reports Mixed Quarterly Results, Affirms Guidance

October 10, 2023 | msn.com

Neogen (NASDAQ:NEOG) Drops on Disappointing Q1 Numbers

October 10, 2023 | markets.businessinsider.com

Why Is Food Safety Firm Neogen Stock Trading Lower Today?

October 10, 2023 | finance.yahoo.com

Here's Why Neogen (NEOG) is Poised for a Turnaround After Losing -14.43% in 4 Weeks

October 10, 2023 | finance.yahoo.com

Unveiling Neogen (NEOG)'s Value: Is It Really Priced Right? A Comprehensive Guide

October 10, 2023 | seekingalpha.com

Neogen Corporation 2024 Q1 - Results - Earnings Call Presentation

October 10, 2023 | finanznachrichten.de

Neogen Corporation: Neogen Announces First-Quarter 2024 Results

October 10, 2023 | markets.businessinsider.com

Neogen Q1 Results Miss Estimates; Backs FY24 Outlook

October 10, 2023 | msn.com

Neogen Non-GAAP EPS of $0.11 misses by $0.02, revenue of $229M misses by $2.1M

See More Headlines

Receive NEOG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Neogen and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 10/10/2023
Today: 11/29/2023
Next Earnings (Estimated): 1/04/2024
Fiscal Year End: 5/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Diagnostic substances
Sub-Industry: Health Care Supplies
Sector: Medical
Current Symbol: NASDAQ:NEOG
CUSIP: 64049110
CIK: 711377
Web: www.neogen.com
Phone: (517) 372-9200
Fax: 517-372-2006
Employees: 2,640
Year Founded: 1982

Price Target and Rating

Average Stock Price Target: $22.75
High Stock Price Target: $28.00
Low Stock Price Target: $17.50
Potential Upside/Downside: +34.2%
Consensus Rating: Moderate Buy
Rating Score (0-4): 2.50
Research Coverage: 2 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($0.11)
Trailing P/E Ratio: N/A
Forward P/E Ratio: 28.73
P/E Growth: N/A
Net Income: $-22,870,000.00
Net Margins: -2.89%
Pretax Margin: -2.94%
Return on Equity: 3.57%
Return on Assets: 2.46%

Debt

Debt-to-Equity Ratio: 0.28
Current Ratio: 4.23
Quick Ratio: 3.21

Sales & Book Value

Annual Sales: $822.45 million
Price / Sales: 4.46
Cash Flow: $0.92 per share
Price / Cash Flow: 18.44
Book Value: $14.49 per share
Price / Book: 1.17

Miscellaneous

Outstanding Shares: 216,310,000
Free Float: 214,775,000
Market Cap: $3.67 billion
Optionable: Optionable
Beta: 1.08

Social Links

10 Best Cheap Stocks to Buy Now

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

Mr. John Edward Adent (Age 55)
President, CEO & Director
Comp: $1.39M
Mr. Douglas E. Jones (Age 53)
COO & VP
Comp: $692.16k
Mr. David H. Naemura (Age 53)
Chief Financial Officer
Dr. Robert S. Donofrio Ph.D. (Age 48)
VP & Chief Scientific Officer
Sarah Demey
Administrative Manager
Mr. Bill Waelke
Head of Investor Relations
Ms. Amy M. Rocklin Ph.D. (Age 50)
Chief Legal & Compliance Officer and Corporate Secretary
Ms. Julie A. Mann (Age 58)
VP & Chief Human Resources Officer

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

NEOG Stock Analysis - Frequently Asked Questions

Should I buy or sell Neogen stock right now?: 2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Neogen in the last year. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" NEOG shares.
View NEOG analyst ratings or view top-rated stocks.
What is Neogen's stock price target for 2024?: 2 Wall Street research analysts have issued 12 month target prices for Neogen's shares. Their NEOG share price targets range from $17.50 to $28.00. On average, they predict the company's share price to reach $22.75 in the next twelve months. This suggests a possible upside of 34.2% from the stock's current price.
View analysts price targets for NEOG or view top-rated stocks among Wall Street analysts.
How have NEOG shares performed in 2023?: Neogen's stock was trading at $15.23 on January 1st, 2023. Since then, NEOG shares have increased by 11.3% and is now trading at $16.95.
View the best growth stocks for 2023 here.
When is Neogen's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Thursday, January 4th 2024.
View our NEOG earnings forecast.
How were Neogen's earnings last quarter?: Neogen Co. (NASDAQ:NEOG) posted its earnings results on Tuesday, October, 10th. The company reported $0.11 EPS for the quarter, topping analysts' consensus estimates of $0.03 by $0.08. The firm earned $229 million during the quarter, compared to analyst estimates of $231.10 million. Neogen had a positive trailing twelve-month return on equity of 3.57% and a negative net margin of 2.89%. The firm's revenue was up 72.8% compared to the same quarter last year. During the same period last year, the firm posted $0.15 earnings per share.
What ETFs hold Neogen's stock?: ETFs with the largest weight of Neogen (NASDAQ:NEOG) stock in their portfolio include SPDR S&P Health Care Equipment ETF (XHE), iShares Emergent Food and AgTech Multisector ETF (IVEG), VanEck Agribusiness ETF (MOO), Franklin U.S. Small Cap Multifactor Index ETF (FLQS), ProShares MSCI Transformational Changes ETF (ANEW), iShares Russell 2000 Value ETF (IWN), Invesco S&P MidCap 400 GARP ETF (EWMC) and iShares Russell 2000 ETF (IWM).

When did Neogen's stock split?: Neogen's stock split before market open on Tuesday, January 2nd 2018. The 4-3 split was announced on Friday, December 8th 2017. The newly issued shares were distributed to shareholders after the market closes on Friday, December 29th 2017. An investor that had 100 shares of stock prior to the split would have 133 shares after the split.
What guidance has Neogen issued on next quarter's earnings?: Neogen updated its FY 2024 earnings guidance on Tuesday, October, 10th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $955.00 million-$985.00 million, compared to the consensus revenue estimate of $968.41 million.
What is John Adent's approval rating as Neogen's CEO?: 31 employees have rated Neogen Chief Executive Officer John Adent on Glassdoor.com. John Adent has an approval rating of 56% among the company's employees. This puts John Adent in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.
What other stocks do shareholders of Neogen own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Neogen investors own include NVIDIA (NVDA), NIKE (NKE), Pfizer (PFE), AT&T (T), AbbVie (ABBV), Boeing (BA), JPMorgan Chase & Co. (JPM), W. P. Carey (WPC), Advanced Micro Devices (AMD) and Costco Wholesale (COST).
Who are Neogen's major shareholders?: Neogen's stock is owned by a variety of institutional and retail investors. Top institutional investors include Conestoga Capital Advisors LLC (3.03%), Bamco Inc. NY (2.81%), Morgan Stanley (2.64%), Mackenzie Financial Corp (2.48%), William Blair Investment Management LLC (2.22%) and JPMorgan Chase & Co. (1.85%). Insiders that own company stock include Bruce Papesh, Darci L Vetter, David H Naemura, Douglas Edward Jones, James P Tobin, Jason Warren Lilly, John Edward Adent, Ronald D Green, Steven J Quinlan, Terri A Morrical and William T Boehm.
View institutional ownership trends.
How do I buy shares of Neogen?: Shares of NEOG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NASDAQ:NEOG) was last updated on 11/30/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Neogen Stock Price, News & Analysis (NASDAQ:NEOG)

Neogen MarketRank™ Stock Analysis

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

News and Social Media Coverage

News Sentiment

News Coverage This Week

MarketBeat Follows

Company Ownership

Earnings and Valuation

About Neogen Stock (NASDAQ:NEOG)

NEOG Stock Price History

NEOG Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Social Links

Key Executives

Key Competitors

Insiders & Institutions

NEOG Stock Analysis - Frequently Asked Questions

Overall MarketRank^™